PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Risk of early-onset prostate cancer associated with occupation in the Nordic countries.

Abstract Early-onset prostate cancer is often more aggressive and may have a different aetiology than later-onset prostate cancer, but has been relatively little studied to date. We evaluated occupation in relation to early- and later-onset prostate cancer in a large pooled study.
PMID
Related Publications

Occupation and leukemia in Nordic countries.

Cancer incidence among firefighters: 45 years of follow-up in five Nordic countries.

Work-related cancer in the Nordic countries.

Occupation and relative risk of cutaneous squamous cell carcinoma (cSCC): A 45-year follow-up study in 4 Nordic countries.

Occupation and cancer - follow-up of 15 million people in five Nordic countries.

Authors

Mayor MeshTerms

Occupational Health

Occupations

Keywords

Age

Early-onset prostate cancer

Nordic

Occupation

Standardised incidence ratios

Journal Title european journal of cancer (oxford, england : 1990)
Publication Year Start




PMID- 29132062
OWN - NLM
STAT- MEDLINE
DCOM- 20171212
LR  - 20171212
IS  - 1879-0852 (Electronic)
IS  - 0959-8049 (Linking)
VI  - 87
DP  - 2017 Dec
TI  - Risk of early-onset prostate cancer associated with occupation in the Nordic
      countries.
PG  - 92-100
LID - S0959-8049(17)31304-7 [pii]
LID - 10.1016/j.ejca.2017.09.023 [doi]
AB  - BACKGROUND: Early-onset prostate cancer is often more aggressive and may have a
      different aetiology than later-onset prostate cancer, but has been relatively
      little studied to date. We evaluated occupation in relation to early- and
      later-onset prostate cancer in a large pooled study. METHODS: We used
      occupational information from census data in five Nordic countries from 1960 to
      1990. We identified prostate cancer cases diagnosed from 1961 to 2005 by linkage 
      of census information to national cancer registries and calculated standardised
      incidence ratios (SIRs) separately for men aged 30-49 and those aged 50 or older.
      We also conducted separate analyses by period of follow-up, 1961-1985 and
      1986-2005, corresponding to pre- and post-prostate-specific antigen (PSA)
      screening. RESULTS: For early-onset prostate cancer (n = 1521), we observed the
      highest SIRs for public safety workers (e.g. firefighters) (SIR = 1.71, 95%
      confidence interval [CI]: 1.23-2.31) and military personnel (SIR = 1.97, 95% CI: 
      1.31-2.85). These SIRs were significantly higher than the SIRs for later-onset
      disease (for public safety workers, SIR = 1.10, 95% CI: 1.07-1.14 and for
      military personnel, SIR = 1.09, 95% CI: 1.05-1.13; pheterogeneity = 0.005 and
      0.002, respectively). Administrators and technical workers also demonstrated
      significantly increased risks for early-onset prostate cancer, but the SIRs did
      not differ from those of later-onset disease (pheterogeneity >0.05). While our
      early-onset finding for public safety workers was restricted to the post-PSA
      period, that for military personnel was restricted to the pre-PSA period.
      CONCLUSION: Our results suggest that occupational exposures, particularly for
      military personnel, may be associated with early-onset prostate cancer. Further
      evaluation is needed to explain these findings.
CI  - Copyright (c) 2017 Elsevier Ltd. All rights reserved.
FAU - Barry, Kathryn Hughes
AU  - Barry KH
AD  - Department of Epidemiology and Public Health, University of Maryland School of
      Medicine, Baltimore, MD, USA; Program in Oncology, University of Maryland Marlene
      and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA;
      Occupational and Environmental Epidemiology Branch, Division of Cancer
      Epidemiology and Genetics, National Cancer Institute, National Institutes of
      Health, Bethesda, MD, USA. Electronic address: [email protected]
FAU - Martinsen, Jan Ivar
AU  - Martinsen JI
AD  - Department of Research, Cancer Registry of Norway - Institute of Population-Based
      Cancer Research, Oslo, Norway.
FAU - Alavanja, Michael C R
AU  - Alavanja MCR
AD  - Occupational and Environmental Epidemiology Branch, Division of Cancer
      Epidemiology and Genetics, National Cancer Institute, National Institutes of
      Health, Bethesda, MD, USA.
FAU - Andreotti, Gabriella
AU  - Andreotti G
AD  - Occupational and Environmental Epidemiology Branch, Division of Cancer
      Epidemiology and Genetics, National Cancer Institute, National Institutes of
      Health, Bethesda, MD, USA.
FAU - Blair, Aaron
AU  - Blair A
AD  - Occupational and Environmental Epidemiology Branch, Division of Cancer
      Epidemiology and Genetics, National Cancer Institute, National Institutes of
      Health, Bethesda, MD, USA.
FAU - Hansen, Johnni
AU  - Hansen J
AD  - Danish Cancer Society Research Center, Copenhagen, Denmark.
FAU - Kjaerheim, Kristina
AU  - Kjaerheim K
AD  - Department of Research, Cancer Registry of Norway - Institute of Population-Based
      Cancer Research, Oslo, Norway.
FAU - Koutros, Stella
AU  - Koutros S
AD  - Occupational and Environmental Epidemiology Branch, Division of Cancer
      Epidemiology and Genetics, National Cancer Institute, National Institutes of
      Health, Bethesda, MD, USA.
FAU - Lynge, Elsebeth
AU  - Lynge E
AD  - University of Copenhagen, Copenhagen, Denmark.
FAU - Sparen, Par
AU  - Sparen P
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet,
      Stockholm, Sweden.
FAU - Tryggvadottir, Laufey
AU  - Tryggvadottir L
AD  - Icelandic Cancer Registry, Icelandic Cancer Society, Reykjavik, Iceland; Faculty 
      of Medicine, University of Iceland, Reykjavik, Iceland.
FAU - Weiderpass, Elisabete
AU  - Weiderpass E
AD  - Department of Research, Cancer Registry of Norway - Institute of Population-Based
      Cancer Research, Oslo, Norway; Department of Medical Epidemiology and
      Biostatistics, Karolinska Institutet, Stockholm, Sweden; Genetic Epidemiology
      Group, Folkhalsan Research Center, Helsinki, Finland; Department of Community
      Medicine, Faculty of Health Sciences, University of Tromso, The Arctic University
      of Norway, Tromso, Norway.
FAU - Berndt, Sonja I
AU  - Berndt SI
AD  - Occupational and Environmental Epidemiology Branch, Division of Cancer
      Epidemiology and Genetics, National Cancer Institute, National Institutes of
      Health, Bethesda, MD, USA.
FAU - Pukkala, Eero
AU  - Pukkala E
AD  - Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer
      Research, Helsinki, Finland; Faculty of Social Sciences, University of Tampere,
      Tampere, Finland.
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Multicenter Study
DEP - 20171110
PL  - England
TA  - Eur J Cancer
JT  - European journal of cancer (Oxford, England : 1990)
JID - 9005373
RN  - EC 3.4.21.- (Kallikreins)
RN  - EC 3.4.21.- (kallikrein-related peptidase 3, human)
RN  - EC 3.4.21.77 (Prostate-Specific Antigen)
SB  - IM
MH  - Adult
MH  - Age of Onset
MH  - Humans
MH  - Incidence
MH  - Job Description
MH  - Kallikreins/blood
MH  - Male
MH  - Middle Aged
MH  - Military Personnel
MH  - Occupational Diseases/blood/diagnosis/*epidemiology
MH  - Occupational Exposure/adverse effects
MH  - *Occupational Health
MH  - *Occupations
MH  - Prostate-Specific Antigen/blood
MH  - Prostatic Neoplasms/blood/diagnosis/*epidemiology
MH  - Public Sector
MH  - Risk Assessment
MH  - Risk Factors
MH  - Scandinavian and Nordic Countries/epidemiology
OTO - NOTNLM
OT  - Age
OT  - Early-onset prostate cancer
OT  - Nordic
OT  - Occupation
OT  - Standardised incidence ratios
EDAT- 2017/11/14 06:00
MHDA- 2017/12/13 06:00
CRDT- 2017/11/14 06:00
PHST- 2017/07/21 00:00 [received]
PHST- 2017/09/14 00:00 [revised]
PHST- 2017/09/18 00:00 [accepted]
PHST- 2017/11/14 06:00 [pubmed]
PHST- 2017/12/13 06:00 [medline]
PHST- 2017/11/14 06:00 [entrez]
AID - S0959-8049(17)31304-7 [pii]
AID - 10.1016/j.ejca.2017.09.023 [doi]
PST - ppublish
SO  - Eur J Cancer. 2017 Dec;87:92-100. doi: 10.1016/j.ejca.2017.09.023. Epub 2017 Nov 
      10.